PPT-The Novel Oral Anticoagulants
Author : tatyana-admore | Published Date : 2017-08-27
Fawaz Altuwaijri ACEM trainee Introduction Characteristics of novel anticoagulants Laboratory Testing Reversal in the bleeding patient Introduction Prevalence
Presentation Embed Code
Download Presentation
Download Presentation The PPT/PDF document "The Novel Oral Anticoagulants" is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
The Novel Oral Anticoagulants: Transcript
Fawaz Altuwaijri ACEM trainee Introduction Characteristics of novel anticoagulants Laboratory Testing Reversal in the bleeding patient Introduction Prevalence atrial fibrillation 303 million in 2005. Eliot Williams, MD PhD. Division of Hematology & Medical Oncology. Nothing to disclose. History of anticoagulant therapy. 1910 1920 1930 1940 1950 1960 1970 1980 1990 2000 2010. (. N. OAC). Dan . Moellentin. , . PharmD. , BCPS, Associate Professor . Husson. University. Strokes in Atrial Fibrillation. 1/5 of strokes are caused by a. fib. 1/3 cardiac arrhythmias hospitalizations . Research Advisory Committee. David . Kratville. Senior Environmental Scientist. CDFA – Integrated Pest Control Branch. Vertebrate Pests. Purpose of this training. Overview of rodenticides. History of VPCRAC. UW-Madison Oral History Project. IWU Research . Seminar. 7 October 2015. Jan . Vansina. in . Living with Africa. [After describing the scene of an interview with one of his . Bushong. informants—. Assistant Professor. Department of Internal Medicine – Hospital Medicine Division. Medical Director – UNM Anticoagulation Clinic. Co-Director Antithrombotic Stewardship. Roadmap. Direct oral anticoagulants. Adriana Clark, DDS. 1. Agenda. Introduction. Oral Cancer Facts. Oral Cancer Screening. Mucosa lesion assessment.. - Patient History. - Visual Screening Examination. . Extraoral. and Intraoral (Inspection-Palpation). Dr Than . Kyaw. 27 February 2012. COAGULATION. Complex process of blood clotting. Important part of . hemostasis. Cessation of blood loss from damaged vessel(s). Disorders of coagulation can lead to an increased risk of bleeding (hemorrhage) or clotting (thrombosis). . This presentation is based on the . December 2013. AHRQ WebM&M Spotlight Case. See the full article at . http://webmm.ahrq.gov. . CME credit is available. Commentary by: . Margaret . C. Fang. , MD, MPH, University of California, San Francisco. ?. That . major bleeding . occurs in about . 6.5% of patients on anticoagulants.. . That’s. . 1 patient in 15. . and commonly, GI Bleeding.. That . 1% . is . fatal bleeding . such as intracranial hemorrhage.. existing clots from growing larger. Although anticoagulants are sometimes called blood thinners , they do not actually thin the blood. The job of anticoagulants is to promote the smooth flow of bloo Journal section: Oral Medicine and PathologyPublication Types: Review The reappearance of a forgotten disease in the oral cavity: SyphilisHelena Viñals-Iglesias , Eduardo Chimenos-Küstner Associate Department of Pediatric Dentistry, University of Texas, Health Science Center, San Antonio.Department of Orofacial Sciences, University of California at San Francisco.Disclosures: FIGURE 1. Squamous Christopher B. Granger, MD. On behalf of the IMPACT-AF . Steering. Committee and Investigators. Background. AF is common (34 million people worldwide). AF is associated with a 5-fold increased risk of stroke. Geno J . Merli. , MD, MACP, FSVM, FHM. Professor Medicine & Surgery. Sidney Kimmel Medical College. Thomas Jefferson University Hospitals. Disclosures. Geno J . Merli. , MD. Research Grant BMS-Pfizer: ADIOS study completed 12/2019 Presented ACC Meeting 3/2019.
Download Document
Here is the link to download the presentation.
"The Novel Oral Anticoagulants"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.
Related Documents